BIA applauds record levels of investment in UK biotech sector

24 January 2019
bia

The leading trade group for the British biotech industry - the UK BioIndustry Association (BIA) - has published new figures showing that the sector raised a record £2.2 billion ($2.9 billion) last year, up from the £1.2 billion it raised in 2017.

BIA has also produced a report - Confident capital: backing UK biotech - providing further details of the performance of the sector over the most recent period.

The report finds that over £1.1 billion of venture capital was invested into UK biotech companies, and over £1 billion was raised on public markets in 2018. Across Europe, UK companies accounted for 40% of all biotech venture capital raised and 45% of funding raised through IPOs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology